End-To-End Cell and Gene Therapy Solutions
We share your mission to develop life-changing cell and gene therapies. Accelerate commercialization with end-to-end solutions that deliver reproducible performance and scalability with a simplified path to regulatory approvals.
From discovery, to process development, to clinical and commercial manufacturing, our portfolio of proven solutions helps you achieve faster time-to-market while saving costs. Together, we're setting the standard in cell and gene therapy.
Setting the Standard in Cell and Gene Therapy, Together
Setting the Standard in Reproducible Performance
A high-performing process lays the foundation for reproducible results. Accelerate your cell and gene therapy development with high-throughput technologies that promote process efficiency, optimized critical raw materials that improve yield, and intuitive data analytics that inform decision-making.
Setting the Standard in Streamlined Scale-Up
Designed with scalability in mind, our range of cell culture bioreactors, single-use bags, media, and reagents enable seamless process transfer to larger volumes. Streamline revalidation and optimization from the start by leveraging decades of demonstrated expertise in scalable upstream and downstream solutions.
Setting the Standard for a Simplified Path to Regulatory Compliance
In a rapidly changing landscape, adhering to the latest regulatory requirements is critical to simplifying your registrations and interactions with authorities. Meet efficacy and safety standards with products and services backed by rigorous quality-assurance processes and trusted to deliver approved therapeutics worldwide.
Leverage Decades of Experience in Cell and Gene Therapy
Find the Right Solution
Simplify Your Research, Development, and Manufacturing Workflows
More About CGT From Sartorius
See How Sartorius Drives Your Success in Cell & Gene Therapy
Ready to set the standard in cell and gene therapy with Sartorius? Watch our teaser video to see how we’re helping to make the impossible possible — with our innovative technologies, expert support, and more.
End-to-End Solutions for Your Workflow
Explore Our Cell and Gene Therapy Product Portfolio
Browse our featured products below to find solutions that shorten your time-to-market and improve cost-efficiency at every step of your workflow.
Request Your Sample | Raw Materials and Consumables
To help find the right materials and consumables for your needs, request a sample from our portfolio.
FAQs - Cell and Gene Therapy
Cell therapy uses cells grown ex vivo as treatment. There are two main types — regenerative medicine, where cells or organs are produced for replacement, and gene-modified cell therapy (ex vivo gene therapy), where cells are modified to target disease. Gene therapy is designed to correct, suppress, or insert genes within cells to treat or prevent diseases like cancer and genetic disorders. In vivo gene therapy directly delivers the gene to the patient's body.
Gene therapy can be used for in vivo treatment, where the treatment is injected directly into the patient. In ex vivo treatment, also known as gene-modified cell therapy, the cells are extracted, modified, and then reinjected into the patient. Cell therapy terminology is often used as gene-modified therapies, using cells for treatment. Cells like stem cells and induced pluripotent stem cells can be used for this purpose, as well as for regenerative medicine.
Scientists prefer single-use equipment to mitigate the risk of cross-contamination as well as contamination from viruses and bacteria. In cell therapy, scientists don't perform filtration or chromatography because the cells are the final product. However, a bioreactor and centrifuge are needed to separate, clean, and wash the cells. If you're using a viral vector for gene therapy, you'll also need a bioreactor, along with a complete downstream process including standard filtration, tangential flow filtration, and chromatography.